Suppr超能文献

超声对促排卵过程中子宫内膜变化的描绘。

Sonographic depiction of endometrial changes occurring with ovulation induction.

作者信息

Fleischer A C, Pittaway D E, Beard L A, Thieme G A, Bundy A L, James A E, Wentz A C

出版信息

J Ultrasound Med. 1984 Aug;3(8):341-6. doi: 10.7863/jum.1984.3.8.341.

Abstract

Endometrial thickness and texture were evaluated with serial pelvic sonograms in ten normal, menstruating women and 107 patients undergoing ovulation induction for in vitro fertilization. Serial sonograms were performed in the control group every other day throughout the menstrual cycle, whereas the sonographic examinations of the ovulation induction patients were performed daily in a four- to eight-day time interval after their medications were completed and prior to laparoscopy for follicular aspiration. Endometrial thickness increased (defined as a persistent change greater than or equal to 1 mm) in 21 of 53 women (40 percent) who received human menopausal gonadotropin (HMG). Of the 54 women treated with clomiphene citrate (CC), five of 12 (42 percent) at 50 mg daily, 13 of 33 (39 percent) at 100 mg daily, and one of nine (11 percent) at 150 mg daily were found to have endometrial thickening. Although the frequencies of endometrial thickening in the high-dose CC and HMG groups were not significantly different (P = 0.09), the peak estradiol (E2) levels in the CC (150 mg) group (E2 = 944 +/- 165 pg/ml) were significantly higher (P less than 0.001) than those in the HMG group (E2 = 584 +/- 26 pg/ml). The relatively low frequency of endometrial thickening in women receiving CC (150 mg) despite very high E2 levels, and the decreased incidence of endometrial thickening relative to increasing dosages of CC may reflect an antiestrogenic effect of CC on the endometrium. In those patients undergoing ovulation induction, the texture of the endometrium remained the same in 98 cycles and changed during nine.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对10名正常月经女性和107名接受体外受精促排卵的患者进行盆腔超声检查,评估子宫内膜厚度和质地。对照组在整个月经周期每隔一天进行一次超声检查,而促排卵患者在用药结束后至腹腔镜卵泡抽吸术前的4至8天内每天进行超声检查。接受人绝经期促性腺激素(HMG)治疗的53名女性中有21名(40%)子宫内膜厚度增加(定义为持续变化大于或等于1毫米)。在接受枸橼酸氯米芬(CC)治疗的54名女性中,每日50毫克的12名中有5名(42%)、每日100毫克的33名中有13名(39%)、每日150毫克的9名中有1名(11%)出现子宫内膜增厚。虽然高剂量CC组和HMG组子宫内膜增厚的频率无显著差异(P = 0.09),但CC(150毫克)组的雌二醇(E2)峰值水平(E2 = 944±165皮克/毫升)显著高于HMG组(E2 = 584±26皮克/毫升)(P<0.001)。尽管E2水平非常高,但接受CC(150毫克)治疗的女性子宫内膜增厚频率相对较低,且随着CC剂量增加子宫内膜增厚发生率降低,这可能反映了CC对子宫内膜的抗雌激素作用。在那些接受促排卵的患者中,98个周期子宫内膜质地保持不变,9个周期发生变化。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验